ATA916376A - Verfahren zur herstellung von spritzfertigen injizierbaren losungen von alcalicanrenoat - Google Patents

Verfahren zur herstellung von spritzfertigen injizierbaren losungen von alcalicanrenoat

Info

Publication number
ATA916376A
ATA916376A AT916376A AT916376A ATA916376A AT A916376 A ATA916376 A AT A916376A AT 916376 A AT916376 A AT 916376A AT 916376 A AT916376 A AT 916376A AT A916376 A ATA916376 A AT A916376A
Authority
AT
Austria
Prior art keywords
renoate
alcalican
ready
manufacturing
injectable solutions
Prior art date
Application number
AT916376A
Other languages
English (en)
Other versions
AT345465B (de
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of ATA916376A publication Critical patent/ATA916376A/de
Application granted granted Critical
Publication of AT345465B publication Critical patent/AT345465B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT916376A 1975-12-12 1976-12-10 Verfahren zur herstellung von spritzfertigen injizierbaren loesungen von alcalicanrenoat AT345465B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2556001A DE2556001C3 (de) 1975-12-12 1975-12-12 Spritzfertige injizierbare Lösungen mit einem Gehalt an Alkalicanrenoat

Publications (2)

Publication Number Publication Date
ATA916376A true ATA916376A (de) 1978-01-15
AT345465B AT345465B (de) 1978-09-25

Family

ID=5964213

Family Applications (1)

Application Number Title Priority Date Filing Date
AT916376A AT345465B (de) 1975-12-12 1976-12-10 Verfahren zur herstellung von spritzfertigen injizierbaren loesungen von alcalicanrenoat

Country Status (13)

Country Link
US (1) US4088759A (de)
JP (1) JPS5272811A (de)
AT (1) AT345465B (de)
BE (1) BE849282A (de)
CA (1) CA1062157A (de)
CH (1) CH625123A5 (de)
DE (1) DE2556001C3 (de)
DK (1) DK153441C (de)
FI (1) FI55442C (de)
FR (1) FR2334371A1 (de)
GB (1) GB1509477A (de)
NL (1) NL187517C (de)
SE (1) SE442587B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2950832C2 (de) * 1979-12-18 1983-03-17 Hoechst Ag, 6000 Frankfurt Spritzfertige injizierbare wäßrige Lösungen der Alkalisalze von Canrenoinsäure und Furosemid
DE4228926A1 (de) * 1992-08-31 1994-03-03 Boehringer Mannheim Gmbh Spritzfertige Azosemid-Injektionslösungen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3276959A (en) * 1963-08-08 1966-10-04 Hefa G M B H Stabilized steroid compositions
US3487152A (en) * 1967-02-07 1969-12-30 Hoffmann La Roche Tablets containing 7 - chloro - 2 - methylamino - 5 - phenyl - 3h - 1,4 - benzodiazepine-4-oxide and conjugated estrogenic substances
DE2423550A1 (de) * 1974-05-15 1975-11-27 Boehringer Mannheim Gmbh Pharmazeutisches praeparat

Also Published As

Publication number Publication date
SE442587B (sv) 1986-01-20
CA1062157A (en) 1979-09-11
DK547176A (da) 1977-06-13
DK153441C (da) 1988-11-21
NL187517C (nl) 1991-11-01
DE2556001C3 (de) 1979-11-29
DE2556001B2 (de) 1979-04-12
CH625123A5 (de) 1981-09-15
FR2334371B1 (de) 1980-03-28
AT345465B (de) 1978-09-25
JPS5272811A (en) 1977-06-17
FI55442B (fi) 1979-04-30
US4088759A (en) 1978-05-09
AU2043776A (en) 1977-10-20
NL187517B (nl) 1991-06-03
DK153441B (da) 1988-07-18
FI763564A7 (de) 1977-06-13
SE7613849L (sv) 1977-06-13
DE2556001A1 (de) 1977-06-16
NL7613750A (nl) 1977-06-14
FR2334371A1 (fr) 1977-07-08
JPS5517010B2 (de) 1980-05-08
GB1509477A (en) 1978-05-04
FI55442C (fi) 1979-08-10
BE849282A (fr) 1977-06-10

Similar Documents

Publication Publication Date Title
AT338420B (de) Verfahren zur herstellung von adriamycinen
AT347130B (de) Verfahren zur herstellung von terpolymerisaten
AT346850B (de) Verfahren zur herstellung von epoxiden
AT350793B (de) Verfahren zur herstellung von veraetherten methylolaminotriazinen
AT333774B (de) Verfahren zur herstellung von 3-phenylpyridazonen
AT344154B (de) Verfahren zur herstellung von 5-fluor-2-methyl-1- (p-methylsulfinylbenzyliden)-indenyl-3-essigsaeure
AT335989B (de) Verfahren zur kontinuierlichen herstellung von 2-athylhexanol
ATA662376A (de) Verfahren zur herstellung von terpolymerisaten
ATA916376A (de) Verfahren zur herstellung von spritzfertigen injizierbaren losungen von alcalicanrenoat
ATA425476A (de) Verfahren zur herstellung von steroid-carbon- saeurelactonen
AT334909B (de) Verfahren zur herstellung von substituierten thiocarbaminsaure-s-alkylestern
AT340048B (de) Verfahren zur herstellung von penicillin- und cephalosporinsaure-derivaten
AT340133B (de) Verfahren zur herstellung von athylenpolymerisaten
AT343120B (de) Verfahren zur herstellung von 6-chlor-2-chlormethyl-4-phenylchinazolin-3-oxid
AT341672B (de) Verfahren zur herstellung von 3-methylencephamsulfoxiden
ATA309976A (de) Verfahren zur herstellung von sulfamylbenzoesauren
AT339279B (de) Verfahren zur herstellung von 5-sulfamoylanthranilsauren
AT352110B (de) Verfahren zur herstellung von 3-phenylindol-2- carbonsaeurenitrilen
DD128354A5 (de) Verfahren zur herstellung von aryloxyalkylaminobenzoesaeuren und-saeureestern
AT338747B (de) Verfahren zur herstellung von butandiolen
AT344171B (de) Verfahren zur herstellung von indolyl-pyridyl-ketonen
AT339925B (de) Verfahren zur herstellung von beta-chlorathyltrichlorsilan
ATA233075A (de) Verfahren zur herstellung von 16alpha- und 16beta-methal-9alpha-chlor- oder -flour-21- -desoxyprednisolonestern und -aethern
AT338756B (de) Verfahren zur herstellung von alfa-amino-1-adamantylessigsaure
ATA1009474A (de) Verfahren zur herstellung von 1-acyl-2- methylindolyl -3-alkansauren

Legal Events

Date Code Title Description
ELA Expired due to lapse of time
ELI Erroneous lapse
ELJ Ceased due to non-payment of the annual fee